The Silence in the Powder: Talc, Asbestos, and the Cost of Regulatory Delay
On November 28, 2025, the Food and Drug Administration quietly withdrew a proposed rule that would have required standardized asbestos testing for talc-based cosmetics. The notice appeared, as such things often do, in the Federal Register—bureaucratic language folded into columns of procedural restraint. The agency explained that it intended to issue a more comprehensive rule in the future. Until then, cosmetic manufacturers would not be required to test talc for asbestos.
The withdrawal did not introduce new risk. It merely declined to close an old one.
Asbestos, a naturally occurring mineral once prized for its heat resistance, is now among the most thoroughly documented carcinogens in modern industrial history. Its dangers are not theoretical. They are recorded in pathology reports, court transcripts, epidemiological studies, and death certificates. What remains unsettled is not whether asbestos is harmful, but how often—and how quietly—it continues to enter consumer products through talc, a mineral with which it often shares the same geological bed.
Asbestos in cosmetics and household products has been reported.
Cosmetics occupy a peculiar regulatory space in the United States. They are neither drugs nor food. They do not require premarket approval. Safety determinations are largely left to manufacturers themselves, guided by voluntary standards and uneven enforcement. Against this backdrop, the FDA’s decision to step back from a mandatory testing framework has revived questions that have lingered for decades: Who is responsible for preventing contamination? What does safety mean when it is optional? And what, exactly, are consumers being asked to trust?
Courtesy of Dr Ebru AveSeena
To understand the implications of the withdrawal, SW News spoke with Dr. Ebru AveSeena, MSc, PhD, an immunologist specializing in molecular medicine and the founder and chief scientific officer of AveSeena.
“Right now, there is no federal requirement — none — for companies to test talc for asbestos.”
That absence—plain, unadorned, and legal—now defines the cosmetic marketplace.
A System Built on Voluntary Action
SW News: With the FDA withdrawing its proposed asbestos-testing requirement for talc-based cosmetics, how are responsible companies ensuring product safety in the absence of a federal mandate?
Karpuzoglu: Right now, there’s no law requiring companies to test their talc for asbestos. So safety depends entirely on a company’s willingness to take initiative. Responsible manufacturers are testing their talc through independent laboratories before use, vetting suppliers, requesting full documentation, and, in some cases, avoiding talc altogether. But without a rule, practices vary widely. Some companies are transparent and proactive, while others are not. Consumers are largely relying on corporate integrity.
The phrase “corporate integrity” appears frequently in discussions of cosmetic safety, often as a substitute for enforceable regulation. In practice, it means that two products sitting side by side on a store shelf—identical in appearance, price, and marketing—may have undergone radically different safety evaluations. One may have been tested multiple times using the most sensitive detection methods available. The other may rely on supplier paperwork generated years earlier, or not at all.
This variability is not accidental. It is structural.
The Science of Detection—and Its Limits
SW News: What testing methods currently exist to detect trace levels of asbestos in talc, and how reliable are they compared to what the FDA had originally proposed?
Karpuzoglu: Several testing methods exist, but they differ significantly in sensitivity. X-ray diffraction can identify minerals but may miss trace asbestos. Polarized light microscopy depends heavily on technician skill. Transmission electron microscopy is the most accurate but also the most costly and time-consuming. The FDA’s withdrawn rule would likely have required more sensitive, standardized methods, reducing inconsistencies between companies.
“Not all tests can reliably identify asbestos at very low levels.”
Transmission electron microscopy, or TEM, can detect asbestos fibers too small to be seen with conventional optical methods. It is also expensive. The cost differential between testing methods creates an incentive structure in which lower sensitivity is not a failure but a financial decision. Without a mandate, there is no requirement to choose the most protective option.
Where Contamination Begins
SW News: Talc and asbestos can occur side by side in nature. What steps do manufacturers take at the mining and sourcing stages to prevent contamination?
Karpuzoglu: Contamination risks begin at the source. Responsible companies work with suppliers who understand the geology of the mining site and avoid deposits near asbestos formations. They also test talc at the mine, test it again during processing, and test it once more before the material is used in cosmetics. Full traceability is critical. Companies should be able to show where their talc was mined and how it was handled at each stage.
Historically, talc deposits in regions of New York, Vermont, Italy, and parts of China have been associated with asbestos co-location. The risk is not hypothetical. It is geological. Preventing contamination requires not only testing, but restraint: the decision to leave certain deposits untouched, regardless of commercial value.
Cost, Scale, and Avoidance
SW News: How do cosmetic companies balance the cost and complexity of rigorous testing with consumer safety expectations, especially when there is no current requirement for asbestos screening?
Karpuzoglu: Testing—especially using the most sensitive methods—adds cost. Larger manufacturers may absorb it, but smaller companies sometimes rely solely on supplier documentation because it’s cheaper. Some brands are choosing to eliminate talc entirely to avoid these complications. When an ingredient requires extensive monitoring to ensure safety, companies must weigh whether it is worth the risk at all.
In recent years, a growing number of cosmetic brands have reformulated products to remove talc altogether. “Talc-free” has become both a marketing claim and a risk-management strategy. It is an implicit acknowledgment that the burden of proof has shifted—not because regulation demands it, but because liability, litigation, and public scrutiny do.
Labels Without Guarantees
SW News: Are there industry standards or third-party certifications that consumers can look for to verify that talc-containing products have been screened for asbestos?
Karpuzoglu: Unfortunately, there is no single, universally recognized label that guarantees asbestos testing. Industry groups have voluntary guidelines, and USP-grade talc meets certain purity standards, but these are not comprehensive or mandatory. Some companies use third-party certification, but standards vary. Transparency remains inconsistent across the industry.
The absence of a reliable label leaves consumers to navigate ingredient lists without meaningful context. “Talc” appears as a single word, unaccompanied by information about origin, testing method, or contamination thresholds. The simplicity of the label belies the complexity of the supply chain behind it.
What Regulation Could Be
SW News: What would you like to see from regulators going forward?
Karpuzoglu: A standardized, enforceable testing framework is essential. Consumers deserve consistent protections, not optional ones. A future rule should reflect the best available science, provide clear testing requirements, and ensure that all manufacturers follow the same safety protocols. Voluntary testing cannot replace regulation when public health is at stake.
This is not a call for innovation. It is a call for consistency.
A Record Written in Retrospect
The risks associated with talc contamination are not newly discovered. Court proceedings, FDA surveillance testing, and independent laboratory analyses have repeatedly identified asbestos in cosmetic products over the past half-century. Brands implicated through recalls, litigation, or regulatory testing have included Johnson & Johnson, Claire’s, Justice, CoverGirl, Maybelline, and Revlon. In most cases, contamination was linked to specific batches, not entire product lines. But the pattern has been unmistakable: detection follows exposure, not the other way around.
Johnson & Johnson discontinued its talc-based baby powder in North America in 2020, after decades of assurances and years of legal scrutiny. Other companies issued recalls only after asbestos was found—not because it was required to be ruled out beforehand.
The Space Between Knowledge and Action
The FDA’s withdrawal does not erase the science. It postpones its application.
In the interim, the cosmetic marketplace continues to operate on a sliding scale of precaution. Some companies test aggressively. Others do not. Consumers, meanwhile, are left with the illusion of uniform safety—a shelf full of products governed by the same laws, but not the same standards.
Regulation, when it works, is invisible. Its success is measured in harms that do not occur, in exposures that never happen, in questions consumers never have to ask. The absence of such regulation is quieter still. It announces itself only after the fact.
For now, talc remains legal, asbestos testing remains optional, and the burden of discernment rests with the public. The powder is still soft. The silence around it is not.
Sources
- Federal Register, Nov. 28, 2025, 90 FR 54603, Docket No. FDA-2023-N-4225
- U.S. FDA Cosmetics Program – “What’s New”
- Independent laboratory testing reports and U.S. court records on cosmetic talc litigation
- NORAC HSE Finds Asbestos Contamination in Cosmetic Products
The article, originally published on December 10, was updated on December 25 to incorporate additional sources.
Discover more from SW Newsmagazine
Subscribe to get the latest posts sent to your email.
